HSIC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $84.88
Capitalización Bursátil (MRQ) $9.50B
P/E (TTM) 24.7
BPA (TTM) $3.43
Ingresos (TTM) $13.60B
ROE (TTM) 12.2%
Deuda/Capital (MRQ) 0.3
Rango 52S $62–$92

HSIC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Divisiones de acciones 3
Fecha ex-dividendo División Tipo
8 de febrero de 2019 51-for-40 Adelante
15 de septiembre de 2017 2-for-1 Adelante
1 de marzo de 2005 2-for-1 Adelante

Acerca de Henry Schein, Inc. - Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.

History

In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.

In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.

Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.

In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.

Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.

In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.

In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.

Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.

In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.

In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.

In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.

On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.

In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.

In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.

Operations

Dental

In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.

Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.

Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.

In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.

In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.

In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.

In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.

In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.

In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.

In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.

Henry Schein One

In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.

In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.

In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.

In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.

Medical

In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.

In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.

In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.

In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).

In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).

Former division

Animal health

Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.

Philanthropy

In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.

Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.

In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.

Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.

In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.

Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.

In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealth Care industriaHealth Care empleados25 000 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$13.18B
2016-12-31 → 2025-12-27
BPA$3.27
2016-12-31 → 2025-12-27
Flujo de caja libre$573M
2016-12-31 → 2025-12-27
Margen neto3.0%
2016-12-31 → 2025-12-27
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años HSIC promedio 5A Mediana de Pares Veredicto
P/E (TTM) 24.7promedio 5A ≈21.5 ≈21.5 22.9 Sobrevalorado
P/S (TTM) 0.7promedio 5A ≈0.8 ≈0.8 0.5 Sobrevalorado
P/C (MRQ) 3.0promedio 5A ≈2.8 ≈2.8 · ·
EV / EBITDA 10.7promedio 5A ≈10.4 ≈10.4 · ·
Precio / FCF (TTM) 16.7promedio 5A ≈18.5 ≈18.5 · ·
Precio / Flujo de Caja (TTM) 13.6promedio 5A ≈14.8 ≈14.8 14.0 Valor razonable
EV / Revenue (EV / Ingresos) 0.8promedio 5A ≈0.8 ≈0.8 · ·
EV / FCF 18.0promedio 5A ≈18.9 ≈18.9 · ·
Precio / Valor Contable Tangible (MRQ) 4.3 · · ·
PEG Ratio (Ratio PEG) ≈8.2 · · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media 0.97%
Próximo informe Nov 02, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Ago 11, 2026 $1.27 $1.26 0.67%
31 de marzo de 2026 May 12, 2026 $1.32 $1.24 6.3%
31 de diciembre de 2025 $1.34 $1.33 1.1%
30 de septiembre de 2025 $1.38 $1.30 5.8%
30 de junio de 2025 $1.10 $1.22 -9.5%
31 de marzo de 2025 $1.15 $1.13 1.6%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 17
Métrica Tendencia 20252024202320222021202020192018201720162015
Revenue $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B$8.88B$11.57B$10.63B
Cost of Revenue $9.08B$8.66B$8.48B$8.82B$8.73B$7.30B$6.89B$6.51B$6.14B$8.35B$7.62B
Gross Profit $4.11B$4.02B$3.86B$3.83B$3.67B$2.82B$3.09B$2.91B$2.75B$3.23B$3.01B
SG&A Expense $3.08B$3.03B$2.96B$2.77B$2.63B$2.09B$2.36B$2.22B$2.07B$2.41B$2.24B
Operating Expenses ·······$2.70B$2.53B$2.41B·
Operating Income $653M$621M$615M$747M$852M$535M$718M$601M$670M$772M$734M
Interest Expense $150M$131M$87M$35M$27M$41M$51M$76M$51M$32M$26M
Interest Income $33M$24M$17M$8M$6M$10M$16M$15M$12M$13M$13M
Other Non-op $-3M$-1M$-3M$1M$0$-4M$-3M$-3M$-1M$3M$-141.0K
Pretax Income $533M$513M$542M$721M$831M$500M$680M$537M$630M$756M$721M
Income Tax $126M$128M$120M$170M$198M$95M$160M$107M$309M$218M$211M
Net Income $398M$390M$416M$538M$631M$404M$695M$536M$406M$507M$479M
EPS (Basic) $3.29$3.07$3.18$3.95$4.51$2.83$4.70$3.51$2.59$3.14$2.89
EPS (Diluted) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49$2.57$3.10$2.85
Shares (Basic) 120,813,977126,788,997130,618,990136,064,221140,090,889142,504,193147,817,000152,656,000156,787,000161,641,000165,687,000
Shares (Diluted) 121,717,876127,779,228131,748,171137,755,670141,772,781143,403,682149,257,000153,707,000158,208,000163,723,000168,250,000
EBITDA $964M$918M$863M$959M$1.06B$721M$903M$961M·$941M$893M
Balance general 26
Métrica Tendencia 20252024202320222021202020192018201720162015
Cash & Equivalents $156M$122M$171M$117M$118M$421M·$57M$158M$62M$72M
Receivables $1.65B$1.48B$1.86B$1.44B$1.45B$1.42B$1.25B$1.17B$1.52B$1.25B$1.23B
Inventory $2.00B$1.81B$1.81B$1.96B$1.86B$1.51B$1.43B$1.42B$1.93B$1.67B$1.51B
Prepaid Expense $655M$569M$639M$466M$413M$433M$445M$451M$455M$361M$361M
Current Assets $4.46B$3.98B$4.49B$3.99B$3.84B$3.79B$3.23B$4.18B$4.09B$3.34B$3.23B
PP&E (Net) ····$366M$342M$330M$314M$375M$334M$318M
PP&E (Gross) $1.38B$1.20B$1.17B$956M$916M$868M$799M$905M$990M$865M$797M
Accum. Depreciation $759M$670M$672M$573M$550M$526M$469M$591M$615M$531M$478M
Goodwill $4.21B$3.89B$3.88B$2.89B$2.85B$2.50B$2.46B$2.08B$1.55B$2.02B$1.91B
Intangibles $1.02B$1.02B$916M$587M$668M$479M$573M$376M$670M$621M$593M
Total Assets $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.81B$6.53B
Accounts Payable $1.15B$962M$1.02B$1.00B$1.05B$1.01B$880M$786M$1.15B$1.01B$1.01B
Short-term Debt $764M$650M$264M$103M$51M$73M$24M$951M···
Current Liabilities $3.23B$2.80B$2.68B$2.22B$2.31B$2.28B$2.04B$3.22B$2.83B$2.32B$2.15B
Capital Leases $251M$259M$310M$275M$268M$239M$176M$0···
Deferred Tax $146M$102M$54M$36M$42M$30M$65M$27M$50M$52M$253M
Other Non-current Liabilities $486M$387M$436M$361M$377M$393M$331M$358M$420M$264M$212M
Total Liabilities $6.42B$5.38B$5.42B$3.94B$3.81B$3.46B$3.23B$4.65B$4.21B$3.35B$3.08B
Long-term Debt ···$1.05B$822M······
Total Debt $764M$650M$264M$103M$51M$73M$24M····
Paid-in Capital $177M$0$0$0$0$0$48M$0···
Retained Earnings $3.29B$3.77B$3.86B$3.68B$3.60B$3.45B$3.12B$3.21B$2.94B$2.98B$2.90B
AOCI $-226M$-379M$-206M$-233M$-171M$-108M$-167M$-249M$-130M$-317M$-220M
Stockholders' Equity $3.25B$3.39B$3.65B$3.45B$3.42B$3.35B$3.00B$2.96B$2.81B$2.79B$2.88B
Liabilities + Equity $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.76B$6.50B
Shares Outstanding 115,771,149124,155,884129,247,765131,792,817137,145,558142,462,571143,353,459151,401,668153,690,146158,805,010164,830,640
Flujo de Efectivo 19
Métrica Tendencia 20252024202320222021202020192018201720162015
D&A $311M$297M$248M$212M$210M$186M$185M$144M$134M$170M$159M
Stock-based Comp $39M$39M$39M$54M$78M$9M$45M$33M$37M$58M$45M
Deferred Tax $5M$-61M$-20M$-73M$-11M$-53M$-4M$-25M$1M$-37M$-6M
Amort. of Intangibles $180M$185M$152M$126M$124M$106M$108M$75M$70M$98M$93M
Restructuring $105M$110M$80M$128M$8M··$54M$0$46M$35M
Other Non-cash $-41M$183M$-183M$-129M$-199M$54M$-266M$-54M·$-82M$-90M
Operating Cash Flow $712M$848M$500M$602M$710M$599M$654M$685M$546M$643M$616M
CapEx $139M$148M$147M$96M$79M$49M$76M$71M$62M$70M$72M
Investing Cash Flow $-400M$-430M$-1.14B$-276M$-677M$-115M$-424M$-193M$-342M$-316M$-260M
Debt Issued $489M$120M$1.37B$270M$305M$501M$741.0K$115M$200M$261M$135M
Net Debt Issued $445M$-198M$900M$211M$183M$-110M$-260M$87M·$245M$-66M
Stock Issued $250M$0$0········
Stock Repurchased $850M$385M$250M$485M$401M$74M$525M$200M$450M$550M$300M
Net Stock Activity $-600M$-385M$-250M$-485M$-401M$-74M$-525M$-200M·$-550M$-300M
Financing Cash Flow $-188M$-510M$701M$-315M$-333M$-187M$-216M$-604M$-113M$-327M$-348M
Net Change in Cash $34M$-49M$54M$-1M$-303M$315M$26M$-94M$225M$-10M$-17M
Taxes Paid $128M··········
Free Cash Flow $573M$700M$353M$506M$631M$550M$578M$594M·$545M$515M
Levered FCF $458M$602M$285M$472M$610M$517M$539M$533M·$523M$497M
Rentabilidad 8
Métrica Tendencia 20252024202320222021202020192018201720162015
Gross Margin 31.1%31.7%31.3%30.3%29.6%27.8%30.9%27.2%·28.0%28.3%
Operating Margin 5.0%4.9%5.0%5.9%6.9%5.3%7.2%5.7%·6.7%6.9%
Net Margin 3.0%3.1%3.4%4.2%5.1%4.0%7.0%4.1%·4.4%4.5%
Pretax Margin 4.0%4.0%4.4%5.7%6.7%4.9%6.8%5.3%·6.5%6.8%
EBITDA Margin 7.3%7.2%7.0%7.6%8.6%7.1%9.0%7.3%·8.1%8.4%
ROA 3.7%3.8%4.3%6.3%7.8%5.4%8.9%6.6%·7.6%7.6%
ROE 12.0%11.1%11.7%15.7%18.6%12.7%23.3%18.6%·17.8%16.8%
ROIC 12.4%11.5%12.2%16.1%18.7%12.7%18.2%19.7%·19.7%18.0%
Liquidez y Solvencia 4
Métrica Tendencia 20252024202320222021202020192018201720162015
Current Ratio 1.41.41.71.81.71.71.61.3·1.41.5
Quick Ratio 0.60.60.80.70.70.60.60.5·0.60.6
Debt / Equity 0.20.20.10.00.00.00.0····
Interest Coverage 4.44.77.117.030.912.914.19.6·24.228.2
Eficiencia 3
Métrica Tendencia 20252024202320222021202020192018201720162015
Asset Turnover 1.21.21.31.51.51.41.31.6·1.71.7
Inventory Turnover 4.84.84.54.65.25.04.84.9·5.35.4
Receivables Turnover 8.47.67.58.78.67.68.38.4·9.39.0
Por Acción 5
Métrica Tendencia 20252024202320222021202020192018201720162015
Book Value / Share $28.03$27.33$28.28$26.15$24.97$23.50$20.91$19.56·$35.18$35.00
Revenue / Share $108.32$99.18$93.66$91.81$87.47$70.56$66.90$85.89·$141.36$126.36
Cash Flow / Share $5.85$6.64$3.80$4.37$5.00$4.18$4.38$4.45·$7.52$6.98
Cash / Share $1.35$0.98$1.32$0.89$0.86··$0.53·$0.79$0.87
EPS (TTM) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49·$3.10$2.85
Tasas de Crecimiento 9
Métrica Tendencia 20252024202320222021202020192018201720162015
Revenue YoY 4.0%2.7%-2.4%2.0%22.6%······
Revenue CAGR 3Y 1.4%0.73%6.8%········
Revenue CAGR 5Y 5.4%··········
EPS YoY 7.2%-3.5%-19.2%-12.1%57.8%······
EPS CAGR 3Y -5.8%-11.8%3.9%········
EPS CAGR 5Y 3.0%··········
Net Income YoY 2.1%-6.2%-22.7%-14.7%56.2%······
Net Income CAGR 3Y -9.6%-14.8%0.98%········
Net Income CAGR 5Y -0.30%··········
Valoración (TTM) 14
Métrica Tendencia 20252024202320222021202020192018201720162015
Revenue TTM $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B·$11.57B$10.63B
Net Income TTM $398M$390M$416M$538M$631M$404M$695M$536M·$507M$479M
Market Cap $8.81B$8.74B$9.79B$10.53B$10.28B$9.38B$9.54B$9.25B·$4.72B$5.08B
Enterprise Value $9.42B$9.27B$9.88B$10.51B$10.21B······
P/E 23.323.124.020.416.823.314.317.5·19.221.6
P/S 0.70.70.80.80.80.91.01.0·0.40.5
P/B 2.72.62.73.13.02.83.23.1·1.71.8
P / Tangible Book ·····25.7·····
P / Cash Flow 12.410.319.617.514.515.714.613.5·7.78.7
P / FCF 15.412.527.720.816.317.016.515.6·8.79.9
EV / EBITDA 9.810.111.411.09.6······
EV / FCF 16.413.228.020.816.2······
EV / Revenue 0.70.70.80.80.8······
Earnings Yield 4.3%4.3%4.2%4.9%5.9%4.3%7.0%5.7%·5.2%4.6%

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-272024-12-282023-12-302022-12-312021-12-25
Ingresos $13.18B $12.67B $12.34B $12.65B $12.40B
Margen Bruto % 31.1% 31.7% 31.3% 30.3% 29.6%
Margen Operativo % 5.0% 4.9% 5.0% 5.9% 6.9%
Beneficio neto $398M $390M $416M $538M $631M
EPS Diluido $3.27 $3.05 $3.16 $3.91 $4.45

Propietarios institucionales (13F) 602 declarantes · $11.2B total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 602
Valor en tenencia $11.2B
Nuevas posiciones 64
Posiciones cerradas 60
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
64 (-16 vs trimestre anterior) 60 (+14 vs trimestre anterior) 173 (-3 vs trimestre anterior) 220 (+25 vs trimestre anterior) +9.1M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
Kohlberg Kravis Roberts & Co. L.P. $1 307 257 713 15 652 032 11,68% Acciones
VANGUARD GROUP INC $875 836 080 11 588 199 7,82% Acciones
FMR LLC $630 901 802 7 553 901 5,64% Acciones
BlackRock, Inc. $586 699 894 7 024 663 5,24% Acciones
Artisan Partners Limited Partnership $540 162 844 6 467 467 4,82% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $530 073 795 6 346 669 4,73% Acciones
JPMORGAN CHASE & CO $366 432 667 4 342 929 3,27% Acciones
STATE STREET CORP $359 576 652 4 305 276 3,21% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $345 225 076 4 133 442 3,08% Acciones
AMERICAN CENTURY COMPANIES INC $288 743 396 3 457 175 2,58% Acciones
DIMENSIONAL FUND ADVISORS LP $283 495 786 3 394 242 2,53% Acciones
Southpoint Capital Advisors LP $275 616 000 3 300 000 2,46% Acciones
Invesco Ltd. $263 107 794 3 150 237 2,35% Acciones
CITADEL ADVISORS LLC $243 970 523 2 921 103 2,18% Acciones
GEODE CAPITAL MANAGEMENT, LLC $227 537 373 2 729 030 2,03% Acciones
Palestra Capital Management LLC $204 347 632 2 446 691 1,83% Acciones
BANK OF MONTREAL /CAN/ $176 687 394 2 115 510 1,58% Acciones
MORGAN STANLEY $175 460 572 2 100 819 1,57% Acciones
FIDUCIARY MANAGEMENT INC /WI/ $151 785 323 1 817 353 1,36% Acciones
Burgundy Asset Management Ltd. $151 049 204 2 170 871 1,35% Acciones
LYRICAL ASSET MANAGEMENT LP $122 553 156 1 467 351 1,09% Acciones
UBS Group AG $111 653 127 1 336 843 1,00% Acciones
Swedbank AB $109 479 854 1 310 822 0,98% Acciones
M.D. Sass, LLC $107 485 396 1 286 942 0,96% Acciones
SNYDER CAPITAL MANAGEMENT L P $107 341 992 1 285 225 0,96% Acciones
SCHRODER INVESTMENT MANAGEMENT GROUP $107 262 144 1 272 537 0,96% Acciones
NORGES BANK $103 383 729 1 237 832 0,92% Acciones
BANK OF AMERICA CORP /DE/ $101 266 079 1 212 477 0,90% Acciones
GOLDMAN SACHS GROUP INC $98 070 544 1 174 216 0,88% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $86 593 118 1 036 795 0,77% Acciones
NORTHERN TRUST CORP $80 548 694 964 424 0,72% Acciones
NOMURA HOLDINGS INC $77 065 658 922 721 0,69% Acciones
PZENA INVESTMENT MANAGEMENT LLC $71 888 420 860 733 0,64% Acciones
DME Capital Management, LP $60 013 296 718 550 0,54% Acciones
Ananym Capital Management, LP $57 978 164 694 183 0,52% Acciones
Ulysses Management LLC $55 570 700 665 358 0,50% Acciones
STALEY CAPITAL ADVISERS INC $55 252 489 661 548 0,49% Acciones
VANGUARD FIDUCIARY TRUST CO $45 489 502 544 654 0,41% Acciones
RAYMOND JAMES FINANCIAL INC $42 948 907 514 235 0,38% Acciones
Bank of New York Mellon Corp $42 261 071 505 999 0,38% Acciones
Nuveen, LLC $38 262 099 458 119 0,34% Acciones
DEUTSCHE BANK AG\ $36 574 075 437 908 0,33% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $35 970 895 430 686 0,32% Acciones
Clarkston Capital Partners, LLC $35 168 100 421 074 0,31% Acciones
LONE PEAK GLOBAL INVESTORS LLC $33 404 158 399 954 0,30% Acciones
GAMCO INVESTORS, INC. ET AL $30 537 668 365 633 0,27% Acciones
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $27 342 332 370 995 0,24% Acciones
PRIVATE MANAGEMENT GROUP INC $27 285 483 326 694 0,24% Acciones
FRANKLIN RESOURCES INC $25 575 244 306 217 0,23% Acciones
BNP PARIBAS FINANCIAL MARKETS $25 194 142 301 654 0,23% Acciones

Mostrar todos los 602 propietarios institucionales →

Activistas y propietarios del %+ 5 2 tenencias

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 presentaciones 10 de marzo de 2026 16,40% Enmienda · SEC
KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 presentaciones 8 de agosto de 2025 13,00% Enmienda · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 52 insiders · 25 directivos · 22 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Andrea Albertini CEO, Global Dist. & Tech. 8 de septiembre de 2026 D 116 104 0 0 $0
Thomas C Popeck CEO, Henry Schein Products 19 de marzo de 2026 S 86 182 0 1 $-98 630
Frederick M. Lowery CEO 6 de marzo de 2026 A 95 156 0 0 $0
Bradford C Connett CEO, NA Distribution Group 19 de marzo de 2025 S 62 688 0 0 $0
David B Brous Jr CEO, Strategic Business Group 12 de junio de 2023 S 68 690 0 0 $0
Karen Prange EVP&CEO Gl.AH.Med.Den.Sur.Grp 2 de marzo de 2018 A 62 902 0 0 $0
Lonnie Shoff CEO, Global Strat Port Grp 15 de marzo de 2016 S 31 000 0 0 $0
Ronald N. South SVP & Chief Financial Officer 16 de marzo de 2026 F 88 930 0 0 $0
James P Breslawski President 14 de marzo de 2025 D 200 227 0 0 $0
Bridget A Ross President, Global Medical Grp 6 de marzo de 2017 A 9 654 0 0 $0
Michael Zack President of Int'l Group 7 de marzo de 2013 M 48 716 0 0 $0
Michael S Ettinger EVP & Chief Operating Officer 17 de marzo de 2026 G 112 208 0 0 $0
Christine Zayac Sheehy SVP, Chief Human Res. Officer 16 de marzo de 2026 F 18 454 0 0 $0
Mark E Mlotek EVP, Chief Strategic Officer 16 de marzo de 2026 F 98 372 0 2 $-478 758
Walter Siegel Sr. VP & Chief Legal Officer 14 de marzo de 2025 D 43 191 0 0 $0
Lorelei Mcglynn SVP, Chief Human Res. Officer 6 de septiembre de 2024 S 71 833 0 0 $0
Gerald A Benjamin EVP, Chief Admin. Officer 26 de mayo de 2022 S 95 616 0 0 $0
David Mckinley CCO&Pres. Corp. Com. Dev. Grp. 30 de noviembre de 2018 S 68 012 0 0 $0
Paul Rose SVP, Global Supply Chain 6 de septiembre de 2017 S 17 841 0 0 $0
Robert Minowitz Pres., Int'l Dental Group EMEA 12 de mayo de 2017 S 22 943 0 0 $0
Michael Racioppi SVP Chief Merchandising Offic. 20 de marzo de 2017 M 23 088 0 0 $0
Peter M. Mccarthy Pres., Global Animal Health 13 de marzo de 2017 S 14 277 0 0 $0
James A. Harding SVP, Chief Technology Officer 8 de marzo de 2017 S 16 589 0 0 $0
Stanley Komaroff Senior Advisor 2 de marzo de 2016 F 25 144 0 0 $0
Leonard A David SVP, Chief Compliance Officer 17 de marzo de 2015 S 12 343 0 0 $0
William K Daniel Consejero 12 de junio de 2026 A 7 641 1 0 $691 900
Scott Philip Serota Consejero 6 de marzo de 2026 A 10 790 0 0 $0
Carole T Faig Consejero 6 de marzo de 2026 A 8 025 0 0 $0
Anne H. Margulies Consejero 6 de marzo de 2026 A 23 153 0 0 $0
Mohamad Ali Consejero 6 de marzo de 2026 A 15 075 0 0 $0
Reed Vaughn Tuckson Consejero 6 de marzo de 2026 A 12 520 0 0 $0
Robert J. Hombach Consejero 6 de marzo de 2026 A 5 421 0 0 $0
Bradley T Sheares Consejero 6 de marzo de 2026 A 47 623 0 0 $0
Philip A Laskawy Consejero 6 de marzo de 2026 A 24 538 0 1 $-228 544
Carol Raphael Consejero 21 de mayo de 2025 F 33 538 0 0 $0
Steven Paladino Consejero 4 de marzo de 2024 A 138 272 0 0 $0
Dianne E Rekow Consejero 16 de marzo de 2022 A 18 526 0 0 $0
Barry J Alperin Consejero 16 de marzo de 2022 A 52 473 0 0 $0
Paul Brons Consejero 3 de marzo de 2021 F 16 854 0 0 $0
Shira Goodman Consejero 3 de marzo de 2021 A 5 689 0 0 $0
Lawrence S Bacow Consejero 6 de marzo de 2018 F 10 115 0 0 $0
Donald J Kabat Consejero 6 de marzo de 2018 F 10 874 0 0 $0
Louis W Sullivan Consejero 31 de marzo de 2016 A 14 096 0 0 $0
Norman S Matthews Consejero 31 de marzo de 2016 A 12 890 0 0 $0
Karyn Mashima Consejero 10 de marzo de 2014 F 19 269 0 0 $0
Irving Shafran Consejero 20 de noviembre de 2003 S 750 000 0 0 $0
Stanley M Bergman · 26 de mayo de 2026 G 253 279 0 5 $-7 544 687
Kurt P Kuehn · 10 de marzo de 2026 S 15 420 0 1 $-224 562
Deborah Derby · 6 de marzo de 2026 A 15 093 0 0 $0
Joseph L Herring · 6 de marzo de 2026 A 30 325 0 0 $0
Margaret A Hamburg · 20 de mayo de 2009 M 0 0 0 $0
Pamela Joseph · 16 de noviembre de 2004 S 98 879 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 86 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
RSPH · Invesco Exchange-Traded Fund Trust 1,56% 162 140 SH 1 de octubre de 2026 Diario
GURU · Global X Funds 1,29% 9 179 NS 31 de julio de 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 106 077 NS 31 de julio de 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 0,64% 125 073 SH 1 de octubre de 2026 Diario
FBCV · FIDELITY COVINGTON TRUST 0,36% 7 509 NS 31 de julio de 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,33% 18 150 NS 31 de julio de 2026 N-PORT
IQSM · New York Life Investments ETF Trust 0,33% 12 855 NS 31 de julio de 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 0,28% 54 791 SH 1 de octubre de 2026 Diario
BKMC · BNY Mellon ETF Trust 0,23% 17 140 NS 31 de julio de 2026 N-PORT
DFAT · Dimensional ETF Trust 0,22% 364 767 NS 31 de julio de 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,20% 57 583 NS 31 de julio de 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,20% 2 223 555 SH 1 de octubre de 2026 Diario
DFAS · Dimensional ETF Trust 0,19% 343 006 NS 31 de julio de 2026 N-PORT
ESML · iShares Trust 0,18% 58 607 SH 11 de septiembre de 2026 Diario
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,17% 41 019 NS 31 de julio de 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,17% 1 416 056 SH 19 de agosto de 2026 Diario
FNX · First Trust Exchange-Traded AlphaDE… 0,15% 24 666 NS 31 de julio de 2026 N-PORT
FNK · First Trust Exchange-Traded AlphaDE… 0,15% 3 879 NS 31 de julio de 2026 N-PORT
IYH · iShares Trust 0,14% 57 526 SH 11 de septiembre de 2026 Diario
NUSC · Nushares ETF Trust 0,14% 20 654 NS 31 de julio de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,12% 46 652 NS 31 de julio de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,12% 293 098 SH 19 de agosto de 2026 Diario
SMMD · iShares Trust 0,12% 52 697 SH 11 de septiembre de 2026 Diario
IXJ · iShares Trust 0,11% 51 636 SH 11 de septiembre de 2026 Diario
VB · VANGUARD INDEX FUNDS 0,10% 2 230 411 SH 19 de agosto de 2026 Diario
CURE · Direxion Shares ETF Trust 0,10% 1 905 NS 31 de julio de 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 8 644 SH 1 de octubre de 2026 Diario
VFMF · VANGUARD WELLINGTON FUND 0,09% 7 550 SH 19 de agosto de 2026 Diario
IWS · iShares Trust 0,08% 146 411 SH 10 de septiembre de 2026 Diario
TILT · FlexShares Trust 0,08% 20 224 NS 31 de julio de 2026 N-PORT
WSML · iShares Trust 0,08% 6 020 SH 11 de septiembre de 2026 Diario
VFVA · VANGUARD WELLINGTON FUND 0,07% 7 214 SH 19 de agosto de 2026 Diario
RWL · Invesco Exchange-Traded Fund Trust … 0,07% 77 197 SH 1 de octubre de 2026 Diario
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 6 494 NS 31 de julio de 2026 N-PORT
IWR · iShares Trust 0,06% 403 437 SH 11 de septiembre de 2026 Diario
DFUV · Dimensional ETF Trust 0,06% 98 929 NS 31 de julio de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,05% 13 423 NS 31 de julio de 2026 N-PORT
XOEF · iShares Trust 0,05% 125 SH 11 de septiembre de 2026 Diario
DFAC · Dimensional ETF Trust 0,05% 270 764 NS 31 de julio de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,05% 2 999 NS 31 de julio de 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 5 039 SH 1 de octubre de 2026 Diario
FAB · First Trust Exchange-Traded AlphaDE… 0,04% 858 NS 31 de julio de 2026 N-PORT
CATH · Global X Funds 0,04% 6 000 NS 31 de julio de 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,04% 44 360 SH 1 de octubre de 2026 Diario
DCOR · Dimensional ETF Trust 0,03% 13 104 NS 31 de julio de 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0,03% 22 387 SH 19 de agosto de 2026 Diario
IVE · iShares Trust 0,03% 160 669 SH 11 de septiembre de 2026 Diario
IUSV · iShares Trust 0,03% 83 684 SH 11 de septiembre de 2026 Diario
CHRI · Global X Funds 0,03% 24 NS 31 de julio de 2026 N-PORT
DSI · iShares Trust 0,02% 14 799 SH 10 de septiembre de 2026 Diario
IWD · iShares Trust 0,02% 218 760 SH 11 de septiembre de 2026 Diario
VONV · VANGUARD SCOTTSDALE FUNDS 0,02% 59 466 SH 19 de agosto de 2026 Diario
EGLE · Global X Funds 0,02% 5 NS 31 de julio de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,02% 25 929 NS 31 de julio de 2026 N-PORT
XYLG · Global X Funds 0,02% 132 NS 31 de julio de 2026 N-PORT
TOPC · iShares Trust 0,02% 59 SH 10 de septiembre de 2026 Diario
QVML · Invesco Exchange-Traded Fund Trust … 0,02% 3 104 SH 1 de octubre de 2026 Diario
XCLR · Global X Funds 0,01% 6 NS 31 de julio de 2026 N-PORT
XVV · iShares Trust 0,01% 1 104 SH 11 de septiembre de 2026 Diario
PTLC · Pacer Funds Trust 0,01% 5 070 NS 31 de julio de 2026 N-PORT
IVV · iShares Trust 0,01% 1 220 662 SH 11 de septiembre de 2026 Diario
XYLD · Global X Funds 0,01% 4 788 NS 31 de julio de 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,01% 576 SH 1 de octubre de 2026 Diario
DFUS · Dimensional ETF Trust 0,01% 30 222 NS 31 de julio de 2026 N-PORT
IWB · iShares Trust 0,01% 68 043 SH 11 de septiembre de 2026 Diario
XRMI · Global X Funds 0,01% 70 NS 31 de julio de 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,01% 365 NS 31 de julio de 2026 N-PORT
IWV · iShares Trust 0,01% 27 083 SH 9 de septiembre de 2026 Diario
IYY · iShares Trust 0,01% 4 036 SH 10 de septiembre de 2026 Diario
QDPL · Pacer Funds Trust 0,01% 2 304 NS 31 de julio de 2026 N-PORT
ITOT · iShares Trust 0,01% 123 729 SH 11 de septiembre de 2026 Diario
PHDG · Invesco Actively Managed Exchange-T… 0,01% 77 SH 1 de octubre de 2026 Diario
HCMT · Direxion Shares ETF Trust 0,01% 674 NS 31 de julio de 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,01% 2 513 394 SH 19 de agosto de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,01% 3 089 160 SH 19 de agosto de 2026 Diario
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 81 658 SH 19 de agosto de 2026 Diario
VONE · VANGUARD SCOTTSDALE FUNDS 0,01% 16 261 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 8 309 SH 19 de agosto de 2026 Diario
ESGV · VANGUARD WORLD FUND 0,01% 22 281 SH 19 de agosto de 2026 Diario
SPXL · Direxion Shares ETF Trust 0,01% 7 569 NS 31 de julio de 2026 N-PORT
XTR · Global X Funds 0,01% 4 NS 31 de julio de 2026 N-PORT
DFSV · Dimensional ETF Trust 0,00% 99 NS 31 de julio de 2026 N-PORT
ISCB · iShares Trust · 4 208 SH 11 de septiembre de 2026 Diario
ISCV · iShares Trust · 20 757 SH 11 de septiembre de 2026 Diario
SMLF · iShares Trust · 8 316 SH 11 de septiembre de 2026 Diario
SMMV · iShares Trust · 19 508 SH 19 de agosto de 2026 Diario

HSIC Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 25 analistas COMPRA
Objetivo mediano $100.00 +17,8%
7 28,0% Compra fuerte
8 32,0% Compra
9 36,0% Mantener
1 4,0% Venta
0 0,0% Venta fuerte

Precio objetivo a 12 meses

15 analistas · 2026-09-30

Objetivo medio $97.27 +14,6%

Ahora Precio Actual $84.88
Mín$64.00 Media$97.27 Máx$110.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
HSIC $8.81B 23.3 4.0% 3.0% 12.0% 31.1%
MCK $242.30B 22.5 12.4% 1.2% -224.3% 3.6%
COR $60.61B 39.3 9.3% 0.48% 144.3% 3.6%
CAH · 32.9 14.2% 0.67% -60.5% 3.8%
AHCO $1.35B -19.2 -0.49% -2.2% -4.6% ·
ACH · · · · · ·
MEDS · · · · · ·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa

25

Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Ago 4, 2026